Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 11, 2022

BUY
$5.92 - $9.98 $557,664 - $940,116
94,200 New
94,200 $22,000

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Sona Asset Management (Us) LLC Portfolio

Follow Sona Asset Management (Us) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sona Asset Management (Us) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sona Asset Management (Us) LLC with notifications on news.